News
Hosted on MSN3mon
Novo Nordisk to phase out human insulin pens: reportNovo Nordisk declined to comment on when the company would end production of human insulin pens, adding that the pens were different from those used for its hugely popular GLP-1 drugs, Ozempic and ...
Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
Novo Nordisk is to launch “connected” insulin pens, responding for demands from patients for devices able to communicate with glucose monitoring systems and glucose meters. The Danish pharma ...
Novo Nordisk has decided that it wants its own triple agonist, and is willing to hand over $200 million upfront to United Laboratories’ subsidiary United Biotechnology. In return for the global ...
A U.S. federal court has approved a settlement between Novo Nordisk (NVO) and Minnesota ending a longstanding litigation that accused three leading insulin manufacturers of charging excessive ...
Novo Nordisk joined the many pharmaceutical companies pushing back on government-negotiated drug pricing in the United States.
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pens market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2036" report has been added ...
Two prefilled, disposable insulin pen devices were used: InnoLet and FlexPen (Novo Nordisk). Because the hospital has one preferred formulary manufacturer for insulin analogues, orders from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results